New research identifies a potential treatment target for hepatoblastoma in children

In a novel study appearing in The American Journal of Pathology, investigators studying a mouse model of hepatoblastoma report that the protein heat shock transcription factor 1 (HSF1) is needed for aggressive tumor growth and may be a viable pharmacologic target for hepatoblastoma treatment.

Read more: https://medicalxpress.com/news/2023-01-potential-treatment-hepatoblastoma-common-liver.html